Physician profile
Arturo A Ortiz
NPI 1891748125
$6,176.11
in general payments reported to CMS, 2019-2025
11 companies · $1,953 in 2025
The $1,953 reported for 2025 was more than what 75% of Clinical Neurophysiology providers received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $943 · 2020: $111 · 2021: $205 · 2022: $303 · 2023: $1,761 · 2024: $901 · 2025: $1,953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,578 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $750 · Food and Beverage: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,577.75 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $750.00 |
| Food and Beverage | $287.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,756.29 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,258.25 | 2019-2024 | Eliquis, Zeposia |
| Biogen, INC. | $507.44 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $315.74 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $100.00 | 2019 | |
| Lilly USA, LLC | $90.91 | 2019 | |
| Sunovion Pharmaceuticals INC. | $50.33 | 2021-2022 | |
| Pbg Puerto Rico LLC | $29.17 | 2024 | |
| Medtronic, INC. | $27.64 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $23.08 | 2019 | |
| Acadia Pharmaceuticals INC | $17.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arturo Ortiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.